Certain Common Stock of PetVivo Holdings, Inc. are subject to a Lock-Up Agreement Ending on 11-FEB-2022.
February 10, 2022
Share
Certain Common Stock of PetVivo Holdings, Inc. are subject to a Lock-Up Agreement Ending on 11-FEB-2022. These Common Stock will be under lockup for 185 days starting from 10-AUG-2021 to 11-FEB-2022.
Details:
The officers, directors and certain of stockholders have agreed that they will not offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of, directly or indirectly any shares of common stock or any securities convertible into or exchangeable such common stock, for a period of six months following the date of the final prospectus without the prior written consent of ThinkEquity.
PetVivo Holdings, Inc. is a biomedical device company. The Company is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals. The Companyâs lead product Spryng with OsteoCushion Technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The Company is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals, such as dogs and horses. Its products are derived from biomaterials that simulate a bodyâs cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions, which incorporate such tissue building blocks as collagen, elastin, and proteoglycans such as heparin. The Company has a pipeline of therapeutic devices for both veterinary and human clinical applications.
PETVIVO HOLDINGS, INC. 
